Peripheral blood mononuclear cells (PBMCs) may provide insight into the pathogenesis of Alzheimer’s disease (AD) or Parkinson’s disease (PD). We investigated PBMC samples from 132 well-characterized research participants using seven canonical immune stimulants, mass cytometric identification of 35 PBMC subsets, and single-cell quantification of 15 intracellular signaling markers, followed by machine learning model development to increase predictive power. From these, three main intracellular signaling pathways were identified specifically in PBMC subsets from people with AD versus controls: reduced activation of PLCγ2 across many cell types and stimulations and selectively variable activation of STAT1 and STAT5, depending on stimulant and cell type. Our findings functionally buttress the now multiply-validated observation that a rare coding variant in PLCG2 is associated with a decreased risk of AD. Together, these data suggest enhanced PLCγ2 activity as a potential new therapeutic target for AD with a readily accessible pharmacodynamic biomarker.
Assays that measure intracellular signaling can provide an especially mechanistic assessment of cellular states and are thereby useful for uncovering cellular physiology. Phosphoflow assays quantify responses of intracellular phosphoproteins within targeted cell populations, upon in vitro stimulation by various compounds. Having performed such assays in 11 different autoimmune and inflammatory diseases, we wished to compare the results to discover relationships within and among diseases. Batch artifacts were addressed via modeling batch means as random coefficients from a temporal stochastic process and inclusion of unaffected controls. Importantly, this batch corrective could be applied even in those extreme cases when a disease diagnosis exclusively comprised a single batch because our regression model recognized that the mean of the current batch depends upon the mean of the preceding batch and the time elapsed since the preceding assay day. Unsupervised (t‐distributed stochastic neighbor embedding) and supervised (penalized supervised star plots) two‐dimensional visualizations were employed for biologically meaningful summarization of artifact‐corrected intracellular signaling profiles. Our results showed marked clustering of most diseases, but spreading of others, including systemic lupus erythematosus (SLE) and chronic fatigue syndrome (CFS). This approach holds promise for better understanding the physiological relationship among these diseases and for comparing longitudinally assayed datasets with unbalanced batching in general.